Search results

Order by most recent / most popular / relevance

Results: 1-4 of 4

Senators contend antitrust provisions on generic drugs included in wrong bill

Shook Hardy & Bacon LLP
-
USA
-
November 4 2010

Several Senate Democrats have joined their Republican colleagues in a request that Senate leaders remove the “Preserve Access to Affordable Generics Act” (S. 369) from a fiscal year 2011 appropriations bill (S. 3677

Eleventh Circuit turns aside FTC challenge to pay-for-delay deal

Shook Hardy & Bacon LLP
-
USA
-
May 3 2012

The Eleventh Circuit Court of Appeals has dismissed an antitrust action filed by the Federal Trade Commission (FTC) against a name-brand prescription drug manufacturer (the patent holder) and generic drug companies that entered into pay-for-delay agreements to settle patent infringement claims filed against the generic drug companies

FTC proposes new test for transfers of pharma patents to trigger antitrust review

Shook Hardy & Bacon LLP
-
USA
-
August 16 2012

The Federal Trade Commission has issued for public comment a notice of proposed rulemaking that is intended to clarify “when a transfer of exclusive rights to a patent in the pharmaceutical industry results in a potentially reportable asset acquisition under the Hart Scott Rodino (HSR) Act.”

FTC to accept public comments on competition in pet medications industry through Nov. 1

Shook Hardy & Bacon LLP
-
USA
-
September 21 2012

The Federal Trade Commission (FTC) has reopened the comment period for its October 2, 2012, workshop on competition and consumer protection issues in the pet medications industry

Search results

Senators contend antitrust provisions on generic drugs included in wrong bill

Eleventh Circuit turns aside FTC challenge to pay-for-delay deal

FTC proposes new test for transfers of pharma patents to trigger antitrust review

FTC to accept public comments on competition in pet medications industry through Nov. 1

Current Search

Suggested Facets

Author

Workarea